GW-405,833 (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "GW-405,833" in Serbian language version.

refsWebsite

Global rank Serbian rank

6nih.gov

4^th place

8^th place

3doi.org

2^nd place

4^th place

1archive.org

6^th place

5^th place

archive.org

Clayton N, Marshall FH, Bountra C, O'Shaughnessy CT. „CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain”. Pain. 96 (3): 253—60. април 2002. PMID 11972997.

doi.org

Huffman JW. „The search for selective ligands for the CB2 receptor”. Current Pharmaceutical Design. 6 (13): 1323—37. септембар 2000. PMID 10903395. doi:10.2174/1381612003399347. .
Marriott KS, Huffman JW. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor. Current Topics in Medicinal Chemistry. 8 (3): 187—204. 2008. PMID 18289088. doi:10.2174/156802608783498014. Недостаје или је празан параметар |title= (помоћ).
Beltramo M, Bernardini N, Bertorelli R, Campanella M, Nicolussi E, Fredduzzi S, Reggiani A. CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. European Journal of Neuroscience. 23 (6): 1530—8. март 2006. PMID 16553616. doi:10.1111/j.1460-9568.2006.04684.x. Недостаје или је празан параметар |title= (помоћ).

nih.gov

ncbi.nlm.nih.gov

Huffman JW. „The search for selective ligands for the CB2 receptor”. Current Pharmaceutical Design. 6 (13): 1323—37. септембар 2000. PMID 10903395. doi:10.2174/1381612003399347. .
Marriott KS, Huffman JW. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor. Current Topics in Medicinal Chemistry. 8 (3): 187—204. 2008. PMID 18289088. doi:10.2174/156802608783498014. Недостаје или је празан параметар |title= (помоћ).
Clayton N, Marshall FH, Bountra C, O'Shaughnessy CT. „CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain”. Pain. 96 (3): 253—60. април 2002. PMID 11972997.
Valenzano, K. J.; Tafesse L; Lee, G.; Harrison, J. E.; Boulet JM, Gottshall SL, Mark L, Pearson MS, Miller W, Shan S, Rabadi L, Rotshteyn Y, Chaffer SM, Turchin PI, Elsemore DA, Toth M, Koetzner L, Whiteside GT (април 2005). „Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy”. Neuropharmacology. 48 (5): 658—72. PMID 15814101.
Beltramo M, Bernardini N, Bertorelli R, Campanella M, Nicolussi E, Fredduzzi S, Reggiani A. CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. European Journal of Neuroscience. 23 (6): 1530—8. март 2006. PMID 16553616. doi:10.1111/j.1460-9568.2006.04684.x. Недостаје или је празан параметар |title= (помоћ).

pubmed.ncbi.nlm.nih.gov

Leichsenring A, Andriske M, Bäcker I, Stichel CC, Lübbert H. Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain. Naunyn Schmiedebergs Archives of Pharmacology. 2009 Jan 18. PMID 19152053